| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ACAT1
|
acetyl-CoA acetyltransferase 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACTB
|
actin, beta
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADAMTS15
|
ADAM metallopeptidase with thrombospondin type 1 motif, 15
|
|
ADAMTS4
|
ADAM metallopeptidase with thrombospondin type 1 motif, 4
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA2C
|
adrenoceptor alpha 2C
|
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AGTRAP
|
angiotensin II receptor-associated protein
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
ANXA6
|
annexin A6
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APLN
|
apelin
|
|
APOA4
|
apolipoprotein A-IV
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AR
|
androgen receptor
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ATF5
|
activating transcription factor 5
|
|
ATG4A
|
autophagy related 4A, cysteine peptidase
|
|
ATG4B
|
autophagy related 4B, cysteine peptidase
|
|
ATG4D
|
autophagy related 4D, cysteine peptidase
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2L1
|
BCL2-like 1
|
|
BDKRB2
|
bradykinin receptor B2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRINP3
|
bone morphogenetic protein/retinoic acid inducible neural-specific 3
|
|
C3
|
complement component 3
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CAMLG
|
calcium modulating ligand
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCNC
|
cyclin C
|
|
CCND1
|
cyclin D1
|
|
CCNT1
|
cyclin T1
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCT6B
|
chaperonin containing TCP1, subunit 6B (zeta 2)
|
|
CD180
|
CD180 molecule
|
|
CD274
|
CD274 molecule
|
|
CD80
|
CD80 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CHRM1
|
cholinergic receptor, muscarinic 1
|
|
CHRM3
|
cholinergic receptor, muscarinic 3
|
|
CIT
|
citron rho-interacting serine/threonine kinase
|
|
CLEC2D
|
C-type lectin domain family 2, member D
|
|
CLIP1
|
CAP-GLY domain containing linker protein 1
|
|
CLOCK
|
clock circadian regulator
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
CPO
|
carboxypeptidase O
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRH
|
corticotropin releasing hormone
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYSLTR2
|
cysteinyl leukotriene receptor 2
|
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3
|
|
DLX2
|
distal-less homeobox 2
|
|
DLX5
|
distal-less homeobox 5
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
DUSP5
|
dual specificity phosphatase 5
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELMO1
|
engulfment and cell motility 1
|
|
ENHO
|
energy homeostasis associated
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZR
|
ezrin
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FAIM
|
Fas apoptotic inhibitory molecule
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FN1
|
fibronectin 1
|
|
FOLR2
|
folate receptor 2 (fetal)
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
FSTL3
|
follistatin-like 3 (secreted glycoprotein)
|
|
GCG
|
glucagon
|
|
GDF9
|
growth differentiation factor 9
|
|
GH1
|
growth hormone 1
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNAS
|
GNAS complex locus
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRH2
|
gonadotropin-releasing hormone 2
|
|
GPR68
|
G protein-coupled receptor 68
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRN
|
granulin
|
|
GRP
|
gastrin-releasing peptide
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
HTR4
|
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled
|
|
HTR7
|
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFT57
|
intraflagellar transport 57
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGFBP5
|
insulin-like growth factor binding protein 5
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL10
|
interleukin 10
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL32
|
interleukin 32
|
|
IL34
|
interleukin 34
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF8
|
interferon regulatory factor 8
|
|
IRS4
|
insulin receptor substrate 4
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUND
|
jun D proto-oncogene
|
|
KCNA2
|
potassium channel, voltage gated shaker related subfamily A, member 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ11
|
potassium channel, inwardly rectifying subfamily J, member 11
|
|
KDM3B
|
lysine (K)-specific demethylase 3B
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KLF10
|
Kruppel-like factor 10
|
|
KLK1
|
kallikrein 1
|
|
KNG1
|
kininogen 1
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LTF
|
lactotransferrin
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MATK
|
megakaryocyte-associated tyrosine kinase
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MIR134
|
microRNA 134
|
|
MIR21
|
microRNA 21
|
|
MIR424
|
microRNA 424
|
|
MIR503
|
microRNA 503
|
|
MLNR
|
motilin receptor
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOK
|
MOK protein kinase
|
|
MRGPRD
|
MAS-related GPR, member D
|
|
MSN
|
moesin
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRNR2L1
|
MT-RNR2-like 1
|
|
MTRNR2L10
|
MT-RNR2-like 10
|
|
MTRNR2L2
|
MT-RNR2-like 2
|
|
MTRNR2L3
|
MT-RNR2-like 3
|
|
MTRNR2L4
|
MT-RNR2-like 4
|
|
MTRNR2L5
|
MT-RNR2-like 5
|
|
MTRNR2L6
|
MT-RNR2-like 6
|
|
MTRNR2L7
|
MT-RNR2-like 7
|
|
MTRNR2L8
|
MT-RNR2-like 8
|
|
MTRNR2L9
|
MT-RNR2-like 9
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NDRG2
|
NDRG family member 2
|
|
NDUFA13
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
|
|
NELFA
|
negative elongation factor complex member A
|
|
NELFB
|
negative elongation factor complex member B
|
|
NEUROG2
|
neurogenin 2
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NMU
|
neuromedin U
|
|
NOL3
|
nucleolar protein 3 (apoptosis repressor with CARD domain)
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPB
|
natriuretic peptide B
|
|
NPPC
|
natriuretic peptide C
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR3
|
natriuretic peptide receptor 3
|
|
NPS
|
neuropeptide S
|
|
NPSR1
|
neuropeptide S receptor 1
|
|
NPY
|
neuropeptide Y
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRP1
|
neuropilin 1
|
|
NSA2
|
NSA2 ribosome biogenesis homolog (S. cerevisiae)
|
|
NUCB2
|
nucleobindin 2
|
|
OSTN
|
osteocrin
|
|
OXTR
|
oxytocin receptor
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PAQR6
|
progestin and adipoQ receptor family member VI
|
|
PAQR9
|
progestin and adipoQ receptor family member IX
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA2
|
protein disulfide isomerase family A, member 2
|
|
PDIA3
|
protein disulfide isomerase family A, member 3
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PDYN
|
prodynorphin
|
|
PFDN1
|
prefoldin subunit 1
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PLCB2
|
phospholipase C, beta 2
|
|
PLTP
|
phospholipid transfer protein
|
|
PON1
|
paraoxonase 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit
|
|
PRKAG1
|
protein kinase, AMP-activated, gamma 1 non-catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKD1
|
protein kinase D1
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRL
|
prolactin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP2A
|
RAP2A, member of RAS oncogene family
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RARB
|
retinoic acid receptor, beta
|
|
RARG
|
retinoic acid receptor, gamma
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCBTB1
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1
|
|
RDX
|
radixin
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REST
|
RE1-silencing transcription factor
|
|
RETN
|
resistin
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RLN1
|
relaxin 1
|
|
RLN3
|
relaxin 3
|
|
RN7SK
|
RNA, 7SK small nuclear
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RSAD2
|
radical S-adenosyl methionine domain containing 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A4
|
S100 calcium binding protein A4
|
|
SAT1
|
spermidine/spermine N1-acetyltransferase 1
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SELE
|
selectin E
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SET
|
SET nuclear proto-oncogene
|
|
SHH
|
sonic hedgehog
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD6
|
SMAD family member 6
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SP1
|
Sp1 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SST
|
somatostatin
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
STX1A
|
syntaxin 1A (brain)
|
|
TAAR1
|
trace amine associated receptor 1
|
|
TAC1
|
tachykinin, precursor 1
|
|
TACR1
|
tachykinin receptor 1
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
THG1L
|
tRNA-histidine guanylyltransferase 1-like (S. cerevisiae)
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNIP3
|
TNFAIP3 interacting protein 3
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TTK
|
TTK protein kinase
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNDC15
|
thioredoxin domain containing 15
|
|
TXNDC9
|
thioredoxin domain containing 9
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
UBE2D3
|
ubiquitin-conjugating enzyme E2D 3
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCN2
|
urocortin 2
|
|
UTS2R
|
urotensin 2 receptor
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WASL
|
Wiskott-Aldrich syndrome-like
|
|
WISP2
|
WNT1 inducible signaling pathway protein 2
|
|
WNK3
|
WNK lysine deficient protein kinase 3
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
XRCC6P2
|
X-ray repair complementing defective repair in Chinese hamster cells 6 pseudogene 2
|
|
YY1
|
YY1 transcription factor
|
|
YY2
|
YY2 transcription factor
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
